Optimization of Lipid Nanoparticles for saRNA Expression and Cellular Activation Using a Design-of-Experiment Approach. (2022)
Attributed to:
Future Vaccine Manufacturing Hub: Advancing the manufacture and deployment of cost effective vaccines
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1021/acs.molpharmaceut.2c00032
PubMed Identifier: 35604765
Publication URI: http://europepmc.org/abstract/MED/35604765
Type: Journal Article/Review
Volume: 19
Parent Publication: Molecular pharmaceutics
Issue: 6
ISSN: 1543-8384